More about

Biologic

News
September 19, 2023
1 min read
Save

EHR advisory improves infection screening in patients with autoimmune, rheumatic diseases

EHR advisory improves infection screening in patients with autoimmune, rheumatic diseases

An automated best practice advisory within the electronic health record can improve infectious disease screening in patients with autoimmune and rheumatic conditions, according to data published in Arthritis Care & Research.

News
September 19, 2023
3 min read
Save

Long-term outcomes improve in severe eosinophilic asthma with mepolizumab, benralizumab

Long-term outcomes improve in severe eosinophilic asthma with mepolizumab, benralizumab

Mepolizumab and benralizumab were associated with prolonged reductions in oral corticosteroid use among real-world patients with severe eosinophilic asthma, according to data in The Journal of Allergy and Clinical Immunology: In Practice.

News
August 24, 2023
2 min read
Save

Topical halcinonide may benefit patients with psoriasis with inadequate biologics response

Topical halcinonide may benefit patients with psoriasis with inadequate biologics response

Dermatologists should consider prescribing topical halcinonide 0.1% ointment as an adjunctive therapy for patients with moderate to severe plaque psoriasis that inadequately respond to biologics, according to a study.

News
August 22, 2023
1 min read
Save

Partnership announces addition of novel cancer-killing biologic to glioblastoma trial

Partnership announces addition of novel cancer-killing biologic to  glioblastoma trial

A California-based nonprofit and a biotechnology firm announced the activation of novel biologic ADI-PEG 20 in the GBM AGILE platform trial, a study that evaluates therapies for individuals with newly diagnosed or recurring glioblastoma.

News
August 16, 2023
1 min read
Save

AAOS develops educational material regarding orthobiologics

AAOS develops educational material regarding orthobiologics

The American Academy of Orthopaedic Surgeons developed material designed to educate patients and provide resources on the risks and benefits of orthobiologics, according to a press release.

News
August 16, 2023
2 min read
Save

IBD patients with higher intra-abdominal fat less likely to respond to biologic therapy

IBD patients with higher intra-abdominal fat less likely to respond to biologic therapy

Patients with inflammatory bowel disease and a higher percentage of intra-abdominal visceral adipose tissue were less likely to achieve corticosteroid-free remission when treated with biologics, according to data in Gastroenterology.

News
August 04, 2023
1 min read
Save

Several factors linked with multiple biologic failure in patients with psoriasis

Several factors linked with multiple biologic failure in patients with psoriasis

Factors associated with multiple biologic failure in patients with psoriasis may indicate who would benefit from frequent follow-up, according to a study.

News
August 03, 2023
2 min read
Save

Rheumatology nurses can play ‘unique role’ in improving biosimilar uptake

Rheumatology nurses can play ‘unique role’ in improving biosimilar uptake

AUSTIN, Texas — It is critical for rheumatology providers to have a thorough grasp of biosimilarity to properly respond to patient concerns regarding biosimilars, a presenter said at the 2023 Rheumatology Nurses Society annual conference.

News
August 01, 2023
2 min read
Save

Pediatric patients with palmoplantar plaque psoriasis suffer from ineffective biologics

Pediatric patients with palmoplantar plaque psoriasis suffer from ineffective biologics

Pediatric patients with palmoplantar plaque psoriasis were more likely to use combination treatment due to the inefficacy of biologics as a primary treatment in this indication, according to a study.

News
July 27, 2023
1 min read
Save

Speaker: Manufacturing process may be ‘long journey’ for biologics

Speaker: Manufacturing process may be ‘long journey’ for biologics

WASHINGTON — According to a presenter, the manufacturing process for orthobiologics is a long journey of acquiring sufficient data, an appropriately manufactured supply, approval from the FDA and reimbursement before going to market.

View more